Document is current
Any future updates will be listed below
-
Authors
Glodzik, Dominik
Bosch, Ana
Hartman, Johan https://orcid.org/0000-0002-6500-8527
Aine, Mattias https://orcid.org/0000-0002-0851-5952
Vallon-Christersson, Johan
Reuterswärd, Christel
Karlsson, Anna
Mitra, Shamik https://orcid.org/0000-0001-6995-0600
Niméus, Emma
Holm, Karolina
Häkkinen, Jari https://orcid.org/0000-0002-8466-9179
Hegardt, Cecilia
Saal, Lao H. https://orcid.org/0000-0002-0815-1896
Larsson, Christer
Malmberg, Martin https://orcid.org/0000-0002-9500-8982
Rydén, Lisa
Ehinger, Anna https://orcid.org/0000-0001-9225-7396
Loman, Niklas
Kvist, Anders https://orcid.org/0000-0002-1358-0695
Ehrencrona, Hans https://orcid.org/0000-0002-5589-3622
Nik-Zainal, Serena https://orcid.org/0000-0001-5054-1727
Borg, Åke
Staaf, Johan https://orcid.org/0000-0001-5254-5115
- License Information
-
More Information
Article History
Received: 20 February 2020
Accepted: 2 July 2020
First Online: 27 July 2020
Competing interests
: J.H. has received speakers honoraria and travel support from Roche, advisory board fees from MSD, Novartis and Roche, and institutional research grants from Cepheid and Novartis. Anna Ehinger has received speakers honoraria from Novartis, Amgen, Roche, and advisory board fees from Roche. Ana Bosch has participated in advisory boards for Novartis and Pfizer, and has received travel support from Roche. The remaining authors declare no competing interests.
